Yu-Hsuan Hung Selected Research

Argininosuccinate Lyase

2/2017	Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells.
1/2017	Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
12/2015	Argininosuccinate lyase is a potential therapeutic target in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Hsuan Hung Research Topics

Disease

12	Neoplasms (Cancer) 04/2022 - 06/2014
4	Carcinogenesis 01/2022 - 05/2009
3	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 06/2019
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2017
2	Critical Illness (Critically Ill) 01/2021 - 02/2013
2	Adenocarcinoma of Lung 01/2018 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 06/2014
2	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2015
2	Lung Neoplasms (Lung Cancer) 01/2016 - 05/2009
1	Papillomavirus Infections 01/2022
1	Aspergillosis 01/2021
1	Leukemia 01/2018
1	Stomach Neoplasms (Stomach Cancer) 10/2017
1	Adenocarcinoma 10/2017
1	Melanoma (Melanoma, Malignant) 02/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 11/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Liver Neoplasms (Liver Cancer) 12/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2013
1	Sepsis (Septicemia) 02/2013
1	Insulin Resistance 02/2013

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 12/2017 - 12/2015
3	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2018
3	Argininosuccinate LyaseIBA 02/2017 - 12/2015
3	Arginine (L-Arginine)FDA Link 02/2017 - 12/2015
3	Messenger RNA (mRNA)IBA 11/2016 - 06/2014
2	Semaphorins (Semaphorin)IBA 02/2022 - 01/2022
2	Cyclin D1IBA 02/2022 - 10/2017
2	EnzymesIBA 01/2021 - 06/2014
2	Biomarkers (Surrogate Marker)IBA 06/2019 - 02/2013
2	Cyclin A2IBA 02/2017 - 12/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 12/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2022
1	CateninsIBA 02/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	25-hydroxyvitamin DIBA 01/2022
1	TubulinIBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2021
1	galactomannanIBA 01/2021
1	CytokinesIBA 01/2018
1	HomoharringtonineIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	ChemokinesIBA 01/2018
1	DNA VaccinesIBA 12/2017
1	Cyclin DIBA 10/2017
1	Cyclin D2IBA 10/2017
1	Cyclin D3IBA 10/2017
1	Protein Kinases (Protein Kinase)IBA 10/2017
1	tyrosine receptor (receptor, tyrosine)IBA 10/2017
1	Amino Acids FDA Link 02/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	UbiquitinIBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	IntegrinsIBA 11/2016
1	DNA (Deoxyribonucleic Acid)IBA 11/2016
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2016
1	ThrombospondinsIBA 01/2016
1	Essential Amino AcidsIBA 12/2015
1	Myristic Acid (Tetradecanoic Acid)IBA 06/2014
1	Acyl Coenzyme A (Acyl CoA)IBA 06/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2014
1	Nonesterified Fatty Acids (NEFA)IBA 06/2014
1	LipidsIBA 06/2014
1	Glucose (Dextrose)FDA LinkGeneric 02/2013
1	CreatinineIBA 02/2013
1	CholesterolIBA 02/2013
1	AlbuminsIBA 02/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2013
1	Fatty Acid-Binding ProteinsIBA 02/2013
1	Hormones (Hormone)IBA 02/2013
1	Cell Adhesion MoleculesIBA 05/2009
1	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 05/2009
1	CarcinogensIBA 05/2009
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 05/2009

Therapy/Procedure

3	Therapeutics 04/2022 - 12/2017
2	Immunotherapy 12/2017 - 01/2017